Characteristics and Outcomes of Candidemia in Patients with Durable Left Ventricular Assist Device Support

Kaitlyn L Broderick1, Carli J Peters1, Jeremy A Mazurek2

  • 1From the Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|December 30, 2021
PubMed

Insights

Fungal infections (fungemia) are rare but severe complications in patients with durable left ventricular assist devices (LVADs). This study found fungemia occurred early after LVAD implantation and was associated with serious neurological events.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Device Research

Background:

  • Limited data exist on fungal infections in patients with durable left ventricular assist device (LVAD) support.
  • Fungal infections (fungemia) can be a severe complication in immunocompromised patients and those with indwelling medical devices.

Purpose of the Study:

  • To characterize the epidemiology and clinical outcomes of fungemia in patients with LVAD support.
  • To identify risk factors and common pathogens associated with fungemia in this population.

Main Methods:

  • Retrospective review of patients with LVAD support from January 2012 to June 2020 at a large academic institution.
  • Analysis of patient demographics, clinical presentation, causative fungal species, treatment, and outcomes.

Main Results:

  • Fungemia occurred in 1.4% (5/336) of LVAD patients, diagnosed early post-implantation (mean 14.4 days).
  • Candida species were the causative agents, with most isolates susceptible to fluconazole.
  • Neurological complications, including stroke, were observed. Two patients were transplanted, and two remained on suppressive therapy.

Conclusions:

  • Fungemia is a rare, severe, and early complication in LVAD patients.
  • Prompt diagnosis and appropriate antifungal therapy are crucial for managing fungemia in LVAD recipients.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
38
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
43
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
517
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
73